| |
|
|
|
Xtalks, Online
2025-11-11
Analytical and process development (PD/AD) strategies directly impact how quickly and reliably cell therapies reach patients. Join this webinar to explore integrated PD/AD expertise that delivers robust, regulatory-ready assays and accelerates cell therapy development.
The featured speakers will share case studies on rapid potency assay creation for AAV and mRNA products, along with additional optimized and transferable solutions.
Attendees will join a live poll on PD/AD challenges, with results discussed in real time.
The session will showcase standalone analytical services, including potency assay development, flow cytometry modules and cell therapy assay platforms.
Register for this webinar to learn how integrated PD/AD strategies can accelerate cell therapy development through regulatory-ready assays.
Keywords: Analytical Development, Analytical Testing, Assay Development, Bioanalytical Testing, CDMO/CMO, Cell & Gene Therapies, Cell Therapy, CMC, Drug Development, Potency Assay, Process Development
|
|
|
|
|
|
|
|
Organized by:
|
|
Xtalks |
|
|
Invited Speakers:
|
|
Patrick Kellish, PhD, Senior Scientist, Analytical Development, Kincell Bio
Douglas Mogensen, VP, Commercial Development, Kincell Bio
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
2025-11-11
|
|
|
|
|
|
|
|
Registration:
|
|
Free Registration
|
|
|
E-mail:
|
|
tristan@xtalks.com
|
|
|
|
|
|
|
|
|
|
|
|
|